Browse > Article

Quantitative Structure Activity Relationship between Diazabicyclo-[4.2.0]octanes Derivatives and Nicotinic Acetylcholine Receptor Agonists  

Kim, Eun-Ae (College of Pharmacy, Chung-Ang University)
Jung, Kyoung-Chul (College of Pharmacy, Chung-Ang University)
Sohn, Uy-Dong (College of Pharmacy, Chung-Ang University)
Im, Chae-Uk (College of Pharmacy, Chung-Ang University)
Publication Information
The Korean Journal of Physiology and Pharmacology / v.13, no.1, 2009 , pp. 55-59 More about this Journal
Abstract
Three dimensional quantitative structure activity relationship between diazabicyclo[4.2.0]octanes and nicotinic acetylcholine receptor($h{\alpha}4{\beta}2$ and $h{\alpha}3{\beta}4$) agonists was studied using comparative molecular field analysis(CoMFA) and comparative molecular similarity indices analysis(CoMSIA). From 11 CoMFA and CoMSIA models, CoMSIA with steric and electrostatic fields gave the best predictive models($q^2=0.926$ and 0.945, ${r^2}_{ncv}=0.983$ and 0.988). This study can be used to develop potent $h{\alpha}4{\beta}2$ receptor agonists with low activity on $h{\alpha}3{\beta}4$ subtype.
Keywords
Diazabicyclo[4.2.0]octanes; CoMFA; CoMSIA; Nicotinic acetylcholine receptors(nAChRs);
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Cashin AL, Torrice MM, McMenimen KA, Lester HA, Dougherty DA. Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor. Biochemistry 46: 630-639, 2007   DOI   ScienceOn
2 Girod R, Barazangi N, McGehee D, Role LW. Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39: 2715-2725, 2000   DOI   ScienceOn
3 Hays JT, Ebbert J, Sood A. Efficacy and safety of varenicline for smoking cessation. Am J Med 121: S32-S42, 2008   PUBMED
4 Lape R, Colquhoun D, Sivilotti LG. On the nature of partial agonism in the nicotinic receptor superfamily. Nature 454: 722-727, 2008   PUBMED   ScienceOn
5 Dougherty JJ, Wu J, Nichols RA. $\beta$-Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23: 6740-6747, 2003
6 Frost MJ, Bunnelle HW, Tietje KR, Anderson DJ, Rueter LE, Curzon P, Surowy CS, Jerome JJ, Kohlhaas DK, Buckley MJ, Henry RF, Dyhring T, Ahring PK, Meyer MD. Synthesis and structure-activity relationships of 3,8-diazabicyclo'4.2.0'octane ligands, potent nicotinic acetylcholine receptor agonists. J Med Chem 49: 7843-7853, 2006   DOI   ScienceOn
7 Vincler M, McIntosh JM. Targeting the $\alpha$9 $\alpha$10 nicotinic acetylcholine receptor to treat severe pain. Expert Opinion on Therapeutic Targets 11: 891-897, 2007   DOI   ScienceOn
8 Dehkordi O, Millis RM, Dennis GC, Jazini E, Williams C, Hussain D, Jayam-Trouth A. Expression of $\alpha$-7 and $\alpha$-4 nicotinic acetylcholine receptors by GABAergic neurons of rostral ventral medulla and caudal pons. Brain Res 1185: 95-102, 2007
9 Jensen AA, Frolund B, Liljefors T, Krogsgaard LP. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48: 4705-4745, 2005   DOI   ScienceOn
10 Kuryatov A, Onksen J, Lindstrom J. Roles of accessory subunits in $\alpha$4$\beta$2 nicotinic receptors. Molecular Pharmacology 74: 132-143, 2008   DOI   PUBMED   ScienceOn
11 Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74: 1235-1246, 2007   DOI   ScienceOn
12 SYBYL Molecular Modeling Software. Tripos Inc., St. Louis, USA, 2008
13 Hogg RC, Bertrand D. Neuroscience: What genes tell us about nicotine addiction. Science 306: 983-985, 2004   DOI   PUBMED   ScienceOn
14 Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends. Pharmacol Sci 27: 482-491, 2006   DOI   ScienceOn
15 Owen RT, Serradell N, Rosa E. Ispronicline: nicotinic acetylcholine $\alpha$4$\beta$2 agonist treatment of cognition disorders. Drugs of the Future 33: 197-202, 2008   DOI
16 Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, Changeux JP, Maskos U, Fratta W. Crucial role of $\alpha$4 and $\alpha$6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327, 2008   DOI   ScienceOn
17 Kenny PJ, File SE, Neal MJ. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 75: 2409-2414, 2000   DOI   ScienceOn
18 O'Leary KT, Parameswaran N, Johnston LC, McIntosh JM, Di Monte DA, Quik M. Paraquat exposure reduces nicotinic receptor-evoked dopamine release in monkey striatum. J Pharmacol Exp Ther 327: 124-129, 2008   DOI   ScienceOn